MIBG in diagnosis and therapy. Letter from the editors [0.03%]
放射性碘-131-MIBG诊断和治疗神经内分泌肿瘤专家共识及评论(letter)
Leonard M Freeman,M Donald Blaufox
Leonard M Freeman
(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives [0.03%]
放射性核素镓-68标记的DOTA-多肽和放射药物用于正电子发射断层成像：研究现状、临床应用及未来前景
Wouter A P Breeman,Erik de Blois,Ho Sze Chan et al.
Wouter A P Breeman et al.
In this review we give an overview of current knowledge of (68)Ga-labeled pharmaceuticals, with focus on imaging receptor-mediated processes. A major advantage of a (68)Ge/(68)Ga generator is its continuous source of (68)Ga, independently f...
The next generation of cardiac positron emission tomography imaging agents: discovery of flurpiridaz F-18 for detection of coronary disease [0.03%]
下一代心脏正电子发射断层扫描影像剂的发现：用于检测冠状病患的氟尿皮啶-F-18
Ming Yu,Stephan G Nekolla,Markus Schwaiger et al.
Ming Yu et al.
Myocardial perfusion imaging (MPI) with thallium 201 ((201)Tl) or (99m)Tc based imaging agents has become a major tool for noninvasive identification of coronary artery disease (CAD). However, single photon emission computed tomography (SPE...
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent [0.03%]
一种经组织病理学验证的β淀粉样正电子发射断层显像剂：氟乙氧基丙基氟18放射性同位素标记茋化合物(FBFT)
John Lister-James,Michael J Pontecorvo,Chris Clark et al.
John Lister-James et al.
Florbetapir F-18 is a molecular imaging agent combining high affinity for β-amyloid, pharmacokinetic properties that allow positron emission tomography (PET) imaging within a convenient time after dose administration, and the wide availabi...
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid [0.03%]
用于脑部β-淀粉样蛋白影像的正电子发射断层扫描放射性药物
Shankar Vallabhajosula
Shankar Vallabhajosula
Alzheimer's disease (AD) is defined histologically by the presence of extracellular β-amyloid (Aβ) plaques and intraneuronal neurofibrillary tangles in the cerebral cortex. The diagnosis of dementia, along with the prediction of who will ...
The next generation of positron emission tomography radiopharmaceuticals in oncology [0.03%]
肿瘤学中正电子发射断层扫描放射性药物的下一代发展
Samuel L Rice,Celeste A Roney,Pierre Daumar et al.
Samuel L Rice et al.
Although (18)F-fluorodeoxyglucose ((18)F-FDG) is still the most widely used positron emission tomography (PET) radiotracer, there are a few well-known limitations to its use. The last decade has seen the development of new PET probes for in...
A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? [0.03%]
PET放射性药物及临床应用概览：新进展如何？
Shankar Vallabhajosula,Lilja Solnes,Brigitte Vallabhajosula
Shankar Vallabhajosula
Positron emission tomography (PET)/computed tomography (CT) is a rapidly expanding imaging modality, thanks to the availability of compact medical cyclotrons and automated chemistry synthesis modules for the production of PET radiopharmaceu...
Guest Editorial: new PET radiopharmaceuticals as molecular imaging probes [0.03%]
客座评论：新型PET放射性药物作为分子影像探针
Shankar Vallabhajosula
Shankar Vallabhajosula
Letter from the editors: positron emission tomography radiopharmaceuticals-current status [0.03%]
主编来信：正电子发射体层摄影放射性药物的现状
Leonard M Freeman,M Donald Blaufox
Leonard M Freeman
Breast cancer imaging devices [0.03%]
乳腺癌影像设备
Renee M Moadel
Renee M Moadel
Conventional mammography is a screening procedure constrained by low specificity in the detection of breast cancer. Approximately 40% of women undergoing mammography screening have dense breast tissue, and conventional mammographic imaging ...